Ignite Creation Date:
2024-05-06 @ 2:02 PM
Last Modification Date:
2024-10-26 @ 1:24 PM
Study NCT ID:
NCT04197713
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-11-08
First Post:
2019-12-12
Brief Title:
Testing the Sequential Combination of the Anti-cancer Drugs Olaparib Followed by Adavosertib AZD1775 in Patients With Advanced Solid Tumors With Selected Mutations and PARP Resistance STAR Study
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-06-30
Start Date Type:
ACTUAL
Primary Completion Date:
2023-02-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-09-21
Completion Date Type:
ESTIMATED
First Submit Date:
2019-12-12
First Submit QC Date:
December 12 2019
Study First Post Date:
2019-12-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-01
Last Update Post Date:
2023-11-08
Last Update Post Date Type:
ACTUAL